The preparation of chlorophyllin copper complex (CCC), shown to be a t
umor promoter in an animal model (Nelson, R.L. (1992) Chlorophyllin, a
n antimutagen, acts as a tumor promoter in the rat-dimethylhydrazine c
olon carcinogenesis model. Anticancer Res., 12, 737-740), also inhibit
s the activities of direct-and indirect-acting mutagens in the Salmone
lla assay and exhibits cytostatic and cytocidal effects toward myeloma
cells. Data from elemental analyses, spectrophotometry and reversed-p
hase high-performance liquid chromatography indicate that CCC preparat
ions generally used in antimutagenic/anticarcinogenic experiments are
variable, complex mixtures of structurally distinct porphyrins lacking
copper in some instances. This variability of the composition may be
a cause for the differences reported for the tumor promotion activity
of CCC. (C) 1997 Elsevier Science Ireland Ltd.